IBDEI2YA ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,47087,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47087,1,3,0)
 ;;=3^Secondary Malig Neop Bone Marrow
 ;;^UTILITY(U,$J,358.3,47087,1,4,0)
 ;;=4^C79.52
 ;;^UTILITY(U,$J,358.3,47087,2)
 ;;=^5001351
 ;;^UTILITY(U,$J,358.3,47088,0)
 ;;=Z12.9^^181^2351^15
 ;;^UTILITY(U,$J,358.3,47088,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47088,1,3,0)
 ;;=3^Screening Malig Neop Site Unspec
 ;;^UTILITY(U,$J,358.3,47088,1,4,0)
 ;;=4^Z12.9
 ;;^UTILITY(U,$J,358.3,47088,2)
 ;;=^5062698
 ;;^UTILITY(U,$J,358.3,47089,0)
 ;;=D17.9^^181^2351^2
 ;;^UTILITY(U,$J,358.3,47089,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47089,1,3,0)
 ;;=3^Benign Neop Lipomatous,Unspec
 ;;^UTILITY(U,$J,358.3,47089,1,4,0)
 ;;=4^D17.9
 ;;^UTILITY(U,$J,358.3,47089,2)
 ;;=^5002020
 ;;^UTILITY(U,$J,358.3,47090,0)
 ;;=E11.9^^181^2352^15
 ;;^UTILITY(U,$J,358.3,47090,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47090,1,3,0)
 ;;=3^Diabetes Type 2 w/o Complications
 ;;^UTILITY(U,$J,358.3,47090,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,47090,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,47091,0)
 ;;=E10.9^^181^2352^12
 ;;^UTILITY(U,$J,358.3,47091,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47091,1,3,0)
 ;;=3^Diabetes Type 1 w/o Complications
 ;;^UTILITY(U,$J,358.3,47091,1,4,0)
 ;;=4^E10.9
 ;;^UTILITY(U,$J,358.3,47091,2)
 ;;=^5002626
 ;;^UTILITY(U,$J,358.3,47092,0)
 ;;=E11.65^^181^2352^14
 ;;^UTILITY(U,$J,358.3,47092,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47092,1,3,0)
 ;;=3^Diabetes Type 2 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,47092,1,4,0)
 ;;=4^E11.65
 ;;^UTILITY(U,$J,358.3,47092,2)
 ;;=^5002663
 ;;^UTILITY(U,$J,358.3,47093,0)
 ;;=E10.65^^181^2352^11
 ;;^UTILITY(U,$J,358.3,47093,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47093,1,3,0)
 ;;=3^Diabetes Type 1 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,47093,1,4,0)
 ;;=4^E10.65
 ;;^UTILITY(U,$J,358.3,47093,2)
 ;;=^5002623
 ;;^UTILITY(U,$J,358.3,47094,0)
 ;;=E86.0^^181^2352^1
 ;;^UTILITY(U,$J,358.3,47094,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47094,1,3,0)
 ;;=3^Dehydration
 ;;^UTILITY(U,$J,358.3,47094,1,4,0)
 ;;=4^E86.0
 ;;^UTILITY(U,$J,358.3,47094,2)
 ;;=^332743
 ;;^UTILITY(U,$J,358.3,47095,0)
 ;;=F03.90^^181^2352^4
 ;;^UTILITY(U,$J,358.3,47095,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47095,1,3,0)
 ;;=3^Dementia w/o Behavioral Disturbance
 ;;^UTILITY(U,$J,358.3,47095,1,4,0)
 ;;=4^F03.90
 ;;^UTILITY(U,$J,358.3,47095,2)
 ;;=^5003050
 ;;^UTILITY(U,$J,358.3,47096,0)
 ;;=F02.80^^181^2352^3
 ;;^UTILITY(U,$J,358.3,47096,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47096,1,3,0)
 ;;=3^Dementia in Oth Diseases w/o Behavioral Disturbance
 ;;^UTILITY(U,$J,358.3,47096,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,47096,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,47097,0)
 ;;=F02.81^^181^2352^2
 ;;^UTILITY(U,$J,358.3,47097,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47097,1,3,0)
 ;;=3^Dementia in Oth Diseases w/ Behavioral Disturbance
 ;;^UTILITY(U,$J,358.3,47097,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,47097,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,47098,0)
 ;;=F32.9^^181^2352^6
 ;;^UTILITY(U,$J,358.3,47098,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47098,1,3,0)
 ;;=3^Depressive Disorder,Major,Single Episode,Unspec
 ;;^UTILITY(U,$J,358.3,47098,1,4,0)
 ;;=4^F32.9
 ;;^UTILITY(U,$J,358.3,47098,2)
 ;;=^5003528
 ;;^UTILITY(U,$J,358.3,47099,0)
 ;;=K57.30^^181^2352^19
 ;;^UTILITY(U,$J,358.3,47099,1,0)
 ;;=^358.31IA^4^2
